Search PubMed⌕ Search

Biomedical subjects

D Jin

Publications and source records attributed to D Jin.

74 records · Page 5Linked to original sources

Influence of glucocorticoid, aspirin, and gamma globulin on interleukin-6 production in the hepatoma cell line.

The current study was designed to observe the effects of drugs used for the treatment of inflammatory diseases (glucocorticoid, aspirin, and gamma globulin) on interleukin 6 (IL-6) production in the liver which may be involved in acute phase protein stimulation. The HUH-7 hepatoma cell line was used in which the IL-6 gene is expressed and produces IL-6 in vitro. The cells were cultured in RPMI 1640 supplemented with 1% fetal calf serum for 12 h prior to addition of these drugs. We collected the cells and supernatants at 24 h, 48 h, and 72 h after addition of glucocorticoid, aspirin, and gamma globulin. IL-6 mRNA in the cells was measured by Northern blot hybridization, while the IL-6 activity in culture supernatants was measured by enzyme-linked immunosorbent assay. At 48 h after addition of glucocorticoid and aspirin, there was a suppression of IL-6 activity in the culture supernatants, which was associated with a decrease of mRNA level in the cells. However, suppression by gamma globulin was not observed. These data demonstrate that glucocorticoid and aspirin are potent regulators of IL-6 synthesis in the hepatoma cell. These components may decrease acute phase protein production via the suppression of IL-6 production in the liver during inflammation.

Aspirin↗

Effects of parenteral nutrition support and chemotherapy on the phasic composition of tumor cells in gastrointestinal cancer.

BACKGROUND: Some clinical studies report the effects of parenteral nutrition in malnourished cancer patients, but few discuss the tumor response to parenteral nutrition plus chemotherapy. If used in combination, the antitumor activity of chemotherapeutic agents may compensate for the tumor stimulation of parenteral nutrition. METHODS: Ninety-two patients with operable gastrointestinal cancer and malnutrition were randomly assigned to four interventions that were administered for 7 days preoperatively: parenteral nutrition alone, parenteral nutrition plus chemotherapy, chemotherapy alone, or no treatment (control). The preintervention and postintervention DNA content, DNA index, percentage of cells in S phase, and tumor cell sensitivity to chemotherapy were measured using image cytometry. RESULTS: Parenteral nutrition resulted in a significant proliferation of tumor cells and a significant increase in the sensitivity of tumor cells to chemotherapy; these effects were not seen in tumors of patients receiving parenteral nutrition plus chemotherapy. There was, however, a nonsignificant increase in tumor cell proliferation and sensitivity to chemotherapy in the tumors of subjects receiving combined therapy compared with those of subjects who received chemotherapy alone. The postintervention nutritional status of both the parenteral nutrition group and the parenteral nutrition plus chemotherapy group were significantly better than that of the control group and the chemotherapy group. The short-term, postoperative clinical outcomes in the chemotherapy group were significantly worse than those in the other three groups. CONCLUSIONS: These results indicate that combining chemotherapy and nutrition support preoperatively for malnourished patients with gastrointestinal cancer improves short-term nutritional status without increasing the proliferation of tumor cells and prevents the postoperative complications that occur when such patients are given chemotherapy without nutrition support. The results also suggest--but do not prove--that parenteral nutrition may increase the effectiveness of chemotherapy in malnourished patients.

Adult↗